Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    12901945 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Phase I Study of Docetaxel and Temsirolimus in Resistant Solid Malignancies
Condition: Resistant Solid Malignancies
Interventions: Drug: Temsirolimus;   Drug: Docetaxel

Study has passed its completion date and status has not been verified in more than two years.